SCHEMBL20087397

SCHEMBL20087397

NC(=O)N(CCN1C(=O)C=CC1=O)CC(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 8/20 0.45
PTGS2 P35354 8/20 0.45
MGLL Q99685 8/20 0.39
FAAH O00519 4/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
HSP90AA1 P07900 1/20 0.38
TLR9 Q9NR96 1/20 0.38
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38
XBP1 P17861 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
RECQL P46063 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GPR35 Q9HC97 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23768573 0.85 PTGS1 (0.51) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL20091650 0.81 ALDH1A1 (0.38) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL21777709 0.79 PTGS1 (0.50) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL20087404 0.78 AKT1 (0.36) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL20087398 0.76 ALDH1A1 (0.31) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL20087403 0.76 PTGS1 (0.47) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL15415401 0.75 PTGS1 (0.54) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL20087391 0.73 PTGS1 (0.45) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL16097610 0.72 PTGS1 (0.43) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL3691144 0.72 PTGS1 (0.43) PTGS1PTGS2MGLLFAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912982-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF Hangzhou Dac Biotech Co., Ltd (CN) 2021-11-24 EP disclosed
EP-3271329-B1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF HANGZHOU DAC BIOTECH CO LTD (CN) 2021-08-18 EP disclosed
US-10646585-B2 Hydrophilic linkers and ligand-drug conjugates thereof HANGZHOU DAC BIOTECH CO., LTD. (CN) 2020-05-12 US disclosed
US-20190125894-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF HANGZHOU DAC BIOTECH CO., LTD. (CN) 2019-05-02 US disclosed
US-20180110876-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF HANGZHOU DAC BIOTECH CO., LTD. (CN) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180110876-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF CD44, HACD3, HACD2 PTGS1 4580/4885PTGS2 4376/4885MGLL 3589/4885
US-20190125894-A1 NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF CD44, HACD3, HACD2 PTGS1 4580/4885PTGS2 4376/4885MGLL 3589/4885
US-10646585-B2 Hydrophilic linkers and ligand-drug conjugates thereof CD44, SELPLG, EPCAM PTGS1 4415/4885PTGS2 4173/4885MGLL 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.